These results suggest that identification of the PKC isoform(s) responsible for vimentin phosphorylation may provide new therapeutic targets for the treatment of Niemann-Pick type C disease and probably for a number of other lysosomal storage disorders with neuropathology that lead to E/L lipid accumulation [35]. The gene discussed is PRRT2; the disease is Niemann-Pick disease type C.